Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Total 13F shares
-
109,524,880
-
Share change
-
-10,298,070
-
Total reported value
-
$1,444,575,514
-
Put/Call ratio
-
6.4%
-
Price per share
-
$13.19
-
Number of holders
-
238
-
Value change
-
-$147,672,656
-
Number of buys
-
87
-
Number of sells
-
146
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q1 2025
As of 31 Mar 2025,
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by
238 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
109,524,880 shares.
The largest 10 holders included
Robeco Institutional Asset Management B.V., RENAISSANCE TECHNOLOGIES LLC, ROYAL BANK OF CANADA, MORGAN STANLEY, BlackRock, Inc., Aikya Investment Management Ltd, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, BNP PARIBAS FINANCIAL MARKETS, and MILLENNIUM MANAGEMENT LLC.
This page lists
239
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.